Clinical Services

World-first lung scanner installed at the Prince of Wales Hospital

18 March, 2022

The world's first dedicated lung scanner, XV Scanner, developed by local researcher Dr Andreas Fouras, has been installed at the Prince of Wales Hospital, Sydney.

WA pharmacist recognised for leadership, contribution to medical safety

16 March, 2022

Kerry Fitzsimons has been recognised by the Society of Hospital Pharmacists of Australia (SHPA) for her leadership and contribution to medical safety in Western Australia and beyond.

Shingrix approved for Australians 18+ at high risk

14 March, 2022

GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.

Locally developed screening tool detects autism at 11 months

14 March, 2022

A new screening tool, developed by researchers from La Trobe University, helps detect autism in very young children.

Cell-based influenza vaccine approved for kids 2+

09 March, 2022

Cell-based seasonal influenza vaccine Flucelvax Quad has been approved for Australian children aged two years and older.

2022 influenza control: virologist recommends four actions

09 March, 2022

With the lifting of border restrictions and quarantine regulations, Australians can anticipate the reintroduction of influenza, according to the authors of an editorial published by the Medical Journal of Australia.

Mild COVID-19 linked to changes in brain structure: study

09 March, 2022

New research reveals the damaging effects of COVID-19 and improves our understanding of how the disease spreads through the central nervous system.

SHPA releases pharmacy standard for heart disease

08 March, 2022

The new pharmacy practice standard recommends patient to pharmacist ratios and quality improvement indicators specific to specialist cardiology pharmacists.

Hepatitis B: new recommendations for clinicians

07 March, 2022

New recommendations for the management of hepatitis B have been released in a bid to improve awareness of chronic hepatitis B among clinicians and to increase detection of cases that currently remain undiagnosed.

Royal Victorian Eye and Ear Hospital implements PSML

07 March, 2022

The Royal Victorian Eye and Ear Hospital is said to be the first hospital in Australia to implement the Pharmacist Shared Medicines List medicine safety initiative.

Missing surgeries will take some time to work through: APHA

04 March, 2022

The latest APRA data shows 11,000 anticipated admissions were missing from private hospitals in the last quarter of 2021.

Landmark clinical practice guidelines for children with CMT

04 March, 2022

Charcot-Marie-Tooth disease is the most common childhood inherited nerve disorder. Yet until now, there have been no guidelines to help patients manage their condition.

COVID-19 antiviral available on the PBS

02 March, 2022

Australians at risk of progressing to severe COVID-19 disease will now be eligible to access an oral antiviral treatment through the PBS.

Breast cancer: how often does overdiagnosis occur?

02 March, 2022

A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.

New rare blood disease treatment on PBS

28 February, 2022

Ultomiris (ravulizumab) will be listed for the first time for patients with paroxysmal nocturnal haemoglobinuria.

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd